Opinions on future, page-103

I find Myer a lot less risky than 90% of the market.

Revenues have been flat and consistent, with 1 - 5% variation and have not bee in constant decline.

Profits have been inconsistent, however the business has not turned a loss the past 3 years.

The business is not subject to a commodity price or FDA approval.

While you're right that it may not turn around any time soon, I really don't think there will be a run on Myer. I think competition has been much the same for the past decade and there are no new threats.

I can sleep sound at night holding this stock as there is underlying value there. Yes it has been a falling knife for most of this year, but purchasing stock at anything under $1.50 in my mind is good value.

I'm a long term holder and value investor and I certainly don't get caught up in week to week fluctuations.